DCF Help: Negative Implied Perpetual FCF Growth Rate

Hello!

Really hoping for advice here. I can't figure out for the life of me why I'm getting a negative implied perpetual FCF growth rate. I'm a new user so I can't link the spreadsheet or send screenshots but any guidance would be great!

11 Comments
 

Assuming you are calculating terminal value with an exit multiple, e.g. EV/EBITDA, a negative implied growth-rate-in-perpetuity means that the discounted terminal value calculated with an exit multiple is lower than what the terminal value would be if FCF were to stay constant in perpetuity. In other words, your valuation via exit multiple is implying that FCF will decrease in perpetuity. This is the interpretation assuming your formula is correct, so check that first.

 

That is the mathematical explanation. If your perpetuity growth is negative then the discount rate is further amplified in your terminal value. However, a negative perpetuity growth implies that at some point, maybe a hundred years forward, your company is negative FCF. Intuitively it makes no sense. Mathematically it works out because that negative FCF is discounted by compounding to a number very small so as to keep the overall TV positive. However, you should probably check your exit multiples to see if your comp set is truly accurate/representative. The perpetuity growth is usually >0.5% and academically should be between inflation and GDP rates. If you get a negative rate number it almost surely implies that your comps are on the lower end of valuation, and you are being too conservative.

 
Most Helpful

Not true that they should all grow between inflation and the economy as a whole. Not all firms will have cash flows into perpetuity, and modeling in a firms decline is perfectly acceptable. One example is a biotech company who is losing patent protection. Another could be a tobacco company.

Modeling in a negative growth rate for firms in dying industries is underutilized in my opinion and leads to overvaluation. For “cash cow” companies focused on milking their legacy products and returning capital to shareholders, they can still be a perfectly good investment even with this consideration.

 

Think about what a negative perpetuity rate means. It means that at some point you will be FCF negative, and then for all years after that, you will be FCF negative. You would use a DCF for this type of company? No, you’d use a comps, because that company either recovers, goes distressed and into bankruptcy/liquidation, or gets acquired. This directly applies to your biotech or tobacco examples. DCFs are used for going concerns...that’s the whole idea behind perpetuity cash flows. If you have a company with temporary negative FCF then you’d not use a DCF because the perpetuity applies on stabilized FCF, not some temporary recession. Best bet: use comps and take 25th percentile, or devise a customized model.

 

I believe a DCF is premised on FCF being positive eventually into the future, not negative. I think OP would use comps for this case, as DCF doesn’t make sense.

 

Quidem non ab dolore et sit ab enim. Nihil corporis odio possimus voluptas. Omnis unde nesciunt id sit hic cupiditate est. Id soluta perspiciatis laudantium quia. Eligendi nihil dolorem maiores dolorem.

Maiores fuga est labore eveniet fugiat nostrum voluptate. Consequatur nesciunt vel eum molestiae consequuntur. At et architecto rerum dicta.

Esse voluptas et voluptatem ratione. Eligendi porro autem adipisci expedita alias est dolorem sapiente. Qui et error illum voluptatum inventore molestiae qui ut. Amet reprehenderit temporibus autem sequi quae natus. Nostrum possimus sed vel qui.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 13 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”